H.R. 10127: Terminating Radical Attempts to Negate Sex Through Government Research Act

This bill would block federal money from being used to conduct, support, or fund research about the effects of certain medical treatments related to gender transition or gender identity.

What counts as covered research

The bill defines covered research broadly as research that studies the effects of:

• Gender-related medical treatment; or

• Any other method of changing a person’s body or appearance so it no longer matches the person’s sex as defined in the bill.

What the bill means by gender-related medical treatment

The bill includes a wide range of treatments under this term. For people it defines as female, it includes medical treatment meant to address the belief that they are not female, such as:

• Certain surgeries, including removal or reconstruction procedures;

• Testosterone or other androgen treatment;

• Puberty blockers, including GnRH agonists and certain drugs that delay or suppress puberty.

For people it defines as male, it includes similar treatment meant to address the belief that they are not male, such as:

• Certain surgeries, including genital reconstruction and other procedures;

• Estrogen treatment;

• Puberty blockers, including GnRH agonists and related drugs that suppress testosterone or delay puberty.

Definitions of male, female, and sex

The bill defines male and female in biological terms tied to reproductive systems. It defines sex as the biological determination of whether a person is male or female.

Practical effect

If enacted, the bill would prevent federal agencies and federally funded programs from paying for or supporting research on the effects of these treatments. That could affect studies at universities, hospitals, research institutions, and other organizations that rely on federal grants or contracts, if the research falls within the bill’s definitions.

Relevant Companies

None found